Skip to main content
TipRanks
Go Ultimate75% OFF

Pharmosa Biopharm Inc. (6875) Q2 2023 Earnings Report

TW:6875 Q2 2023 EPS Results

Actual EPS
-TWD 1.15
Consensus EPS
―
Beat/Miss
―
One Year Ago EPS
-TWD 1.58

TW:6875 Q2 2023 Revenue Results

Actual Revenue
TWD 0
Expected Revenue
―
Beat/Miss
―
YoY Revenue Growth
―

Earnings Announcement Details

Quarter
Q2 2023
Date
08/11/2023
Time
Before Open
Conference Call
Friday, August 11, 2023
TW:6875 Upcoming Earnings

Pharmosa Biopharm Inc.'s next earnings date is estimated for March 3, 2027, based on past reporting schedules.

Q2 2023 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q2 2023 Earnings Slide Deck

No slide deck is available for this earnings event.

Q2 2023 Earnings Call Summary

No earnings call summary is available for this earnings event.

TW:6875 Earnings History

TW:6875 earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Mar 03, 20272026 (Q4)―--0.86――
Nov 18, 20262026 (Q3)―-0.90-0.35-152.68% (-0.54)
Aug 04, 20262026 (Q2)―-0.78-1.0425.27% (+0.26)
May 05, 20262026 (Q1)―-0.73-0.72-1.25% (-0.01)
Mar 10, 20262025 (Q4)―-0.860.27-417.71% (-1.13)
Nov 04, 20252025 (Q3)―-0.35-0.749.14% (+0.34)
Aug 05, 20252025 (Q2)―-1.04-0.45-128.41% (-0.58)
May 06, 20252025 (Q1)―-0.72-0.45-61.43% (-0.27)
Feb 26, 20252024 (Q4)―0.27-0.78134.79% (+1.05)
Nov 14, 20242024 (Q3)―-0.702.03-134.37% (-2.73)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed